Analysis of AmpC β-lactamase Gene in Pseudomonas aeruginosa

The gene and the amino acid sequence of the structural and regulatory region of the Pseudomonas aeruginosa with different resistance patterns were analyzed. Six strains with different resistance patterns were selected and the AmpC β-lactamase was identified. The objective gene fragment was amplified by colonies PCR. The sequences of the PCR-products were analyzed. The DNA sequence of the structural gene ampC and the regulatory genes ampR, ampD and ampE was detected. The 6 strains and the wild-type Pseudomonas aeruginosa are highly homogeneous in structural and regulatory region. Some new mutant points were found.

Detection of AmpC β-lactamase and drug resistance of Enterobacter cloacae

In order to provide useful information for effective control and clinical therapy of infection,the resistance status and the rate of carrying AmpC β-lactamase of Enterobacter cloacae(E.cloacae)were investigated.By VITEK(Bacterial automatic biochemical analyzer),the isolates of E.cloacae were identified and the drug resistance was measured.The AmpC enzyme was detected by thefive-disk diffusion test.Antibiotic sensitivity test showed that the resistance effects of E.cloacae to cefazolin,cefoxitin and ampicillin were more serious,with resistant rates of 80.5%,75.3%and 70.1%,respectively.However,it was more sensitive to Sulperazone(cefoperazone/sulbactam,13.0%),amikacin(16.9%)and ciprofloxacin(19.5%).Meanwhile,the phenotype detection showed that 35.06%(27/77)isolates of E.cloacae produced AmpCβ-lactamase.Most of E.cloacae are multi-drug resistant strains.Sulperazone(cefoperazone/sulbactam),a kind of componentβ-lactamase,is a more effective antibiotic for treating infection caused by E.cloacae.Unreasonable application of the third generation cephalosporins plays an important role in leading to emergence of high-yield AmpCβ-lactamase strains,so antibiotics should be used wisely.

Drug resistance of infectious pathogens after liver transplantation

BACKGROUND: Infection in liver recipients is related to high risk of transplantation failure and mortality. Infectious agents isolated from 55 liver recipients from January 2003 through June 2005 were studied to improve the anti-infectious therapy. METHODS: Pathogens were isolated from routine culture. K-B method was used to examine the drug susceptibility. Extended spectrum β-lactamase, AmpC β-lactamase and Van gene in E. coli were examined by the agar-dilution susceptibility test and Nitrocefin test. RESULTS: Thirty-nine of the 55 recipients got infection. The 513 strains of pathogens isolated from 1861 specimens were predominantly Gram negative bacteria and over 40% of them showed resistance to more than 4 drugs. The positive rates of extended spectrum β-lactamse and AmpC β-lactamse production in E. cloacae were 32.4% and 36.8%, in E. coli were 33.8% and 10.5%, but the rates of these 2 bacteria producing both lactamses were 24.3% and 7.0%. The β-lactamse production rates of Enterococcus faecalis and En-terococcus faecium were 8.8% and 11.1%, and the resistance rates to vancomycin were 11.2% and 18.5%, respectively. CONCLUSIONS: Infectious pathogens isolated from liver recipients are potent and multiple drug resistant. ESBLs and AmpC β-lactamases are the major factors associated with Gram negative drug resistance. The infection of En-terococcal species presents as a particular challenge.